Yonsei University
Clinical trials sponsored by Yonsei University, explained in plain language.
-
New chemo combo shows promise for tough lung cancer
Disease control Not yet recruitingThis Phase 2 trial tests whether adding lurbinectedin to paclitaxel works better than paclitaxel alone for people with advanced small cell lung cancer that has returned after first treatment. About 69 adults will be randomly assigned to one of two groups. The study measures how m…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Smart patches could save hearts: hospital trial tests continuous monitoring
Disease control Not yet recruitingThis study tests whether a wearable monitoring system (ECG patch, temperature patch, and pulse oximeter) can reduce major heart complications in hospitalized patients with heart disease. About 1500 adults will be monitored either with standard care (vital signs every 4-8 hours) o…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug combo aims to stall bone sarcoma in phase 2 trial
Disease control Not yet recruitingThis study tests whether combining two drugs, lenvatinib and everolimus, works better than everolimus alone for people with advanced bone sarcoma (osteosarcoma, Ewing sarcoma, or chondrosarcoma) that has progressed after standard treatment. About 94 adults aged 19 to 79 will be r…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New prostate cancer radiation cuts sessions in half
Disease control Not yet recruitingThis early-phase study tests a shorter, more intense form of carbon-ion radiation for men with low- or intermediate-risk prostate cancer. Instead of the usual 12 sessions, patients receive just 6. The main goal is to check safety and side effects within 90 days. Up to 20 men will…
Phase: PHASE1 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New pacing technique could improve heart function in AF and heart failure patients
Disease control Not yet recruitingThis study compares a newer pacing method called Left Bundle Branch Area Pacing (LBBAP) with the standard coronary sinus pacing for cardiac resynchronization therapy in 44 adults who have both permanent atrial fibrillation and heart failure. The goal is to see if LBBAP better imp…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could an Alzheimer's drug slow Parkinson's? new trial aims to find out
Disease control Not yet recruitingThis study tests whether lecanemab, a drug that clears amyloid plaques in Alzheimer's disease, can also help people with Parkinson's disease who have amyloid buildup in their brains. About 60 adults aged 50-90 with mild cognitive impairment or early dementia will receive lecanema…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New cocktail aims to shrink sarcomas: bevacizumab joins chemo in phase 2 trial
Disease control Not yet recruitingThis phase 2 trial tests whether adding the drug bevacizumab (Onbevzi) to standard chemotherapy (gemcitabine and docetaxel) can shrink tumors better than chemo alone in people with advanced soft tissue sarcoma. About 92 adults who have already had 1-2 prior chemotherapies will be…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can High-Flow oxygen protect babies during C-Section?
Disease control Not yet recruitingThis study looks at whether giving mothers high-flow oxygen during a C-section can help prevent oxygen shortage in the baby. Researchers will compare a special high-flow oxygen device (OptiFlow THRIVE) with standard low-flow oxygen. The trial involves 200 pregnant women scheduled…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug cocktail aims to boost immune attack on lung cancer
Disease control Not yet recruitingThis Phase 2 trial tests two drug combinations for people with a specific genetic mutation (EGFR) in advanced non-small cell lung cancer. One group receives amivantamab plus lazertinib as first treatment; the other gets amivantamab plus chemotherapy after previous treatment stopp…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for rare blood vessel disorders: everolimus trial launches
Disease control Not yet recruitingThis phase 2 trial tests the drug everolimus in 67 people with vascular anomalies (abnormal blood vessels) that haven't responded to standard treatments. The goal is to shrink the lesions and improve symptoms. Participants take everolimus daily for 6 months, with doses adjusted b…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Robot vs. laparoscope: which surgery is safer for early stomach cancer?
Disease control Not yet recruitingThis study compares two types of minimally invasive surgery for early-stage stomach cancer: a newer robotic method using fewer incisions (reduced-port) and the standard laparoscopic method. About 538 patients will be randomly assigned to one of the two surgeries. The main goal is…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Heart attack survivors: new study seeks safer, smarter drug plan after stents
Disease control Not yet recruitingThis study looks at 4,400 people who had a heart attack and got a stent. It tests two drug strategies: one to lower bleeding risk by adjusting blood thinners, and another to lower cholesterol using a milder statin plus ezetimibe. The goal is to find the safest and most effective …
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New heart procedure could reduce transplants in End-Stage heart failure patients
Disease control Not yet recruitingThis study tests a new approach for people with end-stage heart failure and permanent atrial fibrillation who are waiting for a heart transplant or heart pump. Participants will receive either a standard implantable defibrillator (ICD) alone or an ICD plus a special pacing lead a…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New cell therapy takes on Hard-to-Treat stomach cancer
Disease control Not yet recruitingThis early-stage trial tests a new treatment called AB-201 for advanced HER2-positive stomach or gastroesophageal junction cancer. AB-201 uses specially engineered natural killer cells to target and kill cancer cells. The study will enroll 18 adults whose cancer has not responded…
Phase: PHASE1 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for bile duct cancer: maintenance therapy trial launches
Disease control Not yet recruitingThis study is for people with advanced biliary tract cancer whose disease is stable after initial chemotherapy plus immunotherapy. It compares four different maintenance treatments: immunotherapy alone or combined with lenvatinib, venadaparib, or interleukin-2. The goal is to fin…
Phase: PHASE1, PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New radiation approach aims to improve sarcoma surgery outcomes
Disease control Not yet recruitingThis study tests a new type of radiation called carbon ion radiotherapy given before surgery for soft tissue sarcoma. The goal is to see if it is safe and can reduce wound problems after surgery while better controlling the tumor. About 60 adults with sarcoma that can be removed …
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Heart surgery patients may get a simple iron boost to beat anemia
Disease control Not yet recruitingThis study tests whether giving a single dose of intravenous iron the day after heart surgery can reduce the chance of long-term anemia. About 180 adults with low iron or anemia before surgery will be randomly assigned to receive either the iron treatment or a placebo. The main g…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New study tests extra ablation targets to stop A-Fib recurrence
Disease control Not yet recruitingThis study tests if burning extra spots outside the main heart veins can better control persistent atrial fibrillation (a type of irregular heartbeat). About 406 adults having their first ablation will be split into two groups: one gets standard vein isolation, the other gets add…
Phase: NA • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
AI could help ER doctors spot heart attacks faster
Diagnosis Not yet recruitingThis study tests whether an artificial intelligence (AI) tool can help emergency room doctors interpret heart CT scans more accurately. About 530 adults with chest pain and intermediate risk of a heart attack will be randomly assigned to have their scans read with or without AI a…
Phase: NA • Sponsor: Yonsei University • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
AI heart scanner aims to catch silent AFib before it strikes
Diagnosis Not yet recruitingThis study tests whether an artificial intelligence-enhanced ECG (SmartECG-AFrisk) can detect atrial fibrillation (AF) earlier than usual care in 1,230 adults with symptoms like palpitations or dizziness but no prior AF diagnosis. Participants are randomly assigned to either stan…
Phase: NA • Sponsor: Yonsei University • Aim: Diagnosis
Last updated Jun 26, 2026 17:01 UTC
-
Could two blood thinners be better than one for stroke prevention?
Prevention Not yet recruitingThis study compares apixaban alone versus apixaban plus clopidogrel for 30 days in people who have had a stroke and have both atrial fibrillation and atherosclerosis. About 586 participants will be randomly assigned to one of the two treatments. The goal is to see if the combinat…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Prevention
Last updated Jun 27, 2026 07:57 UTC
-
Knee replacement patients may get better pain relief from a continuous nerve block, study suggests
Symptom relief Not yet recruitingThis study compares two methods of pain control after total knee replacement: a single injection of numbing medicine versus a continuous drip through a small tube for 48 hours. About 78 adults aged 40-80 will be randomly assigned to one of the two groups. The goal is to see which…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
Surgeon vs. anesthesiologist: who does the better knee numbing?
Symptom relief Not yet recruitingThis study tests if a surgeon can numb the knee during replacement surgery as effectively as an anesthesiologist using ultrasound. 48 adults having both knees replaced will get one method on each knee. The goal is to see if the surgeon's technique provides equal pain relief and r…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Sound therapy may replace sedatives for C-Section moms
Symptom relief Not yet recruitingThis study tests if listening to binaural beats (special sounds that calm the brain) can lower the amount of sedative drug needed during a C-section. Pregnant women having a C-section under spinal anesthesia often feel anxious and get a drug called midazolam, which can cause side…
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
App aims to stop the dizziness: digital therapy for low blood pressure
Symptom relief Not yet recruitingThis study tests a smartphone app called One.Dr to see if it can reduce the drop in blood pressure that happens when people with orthostatic hypotension stand up. About 86 adults who feel dizzy when standing will use either the real app or a sham version for 6 weeks. The goal is …
Phase: NA • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
New sedative may cut delirium risk in elderly heart surgery patients
Symptom relief Not yet recruitingThis study compares two sedatives, remimazolam and midazolam, to see which one causes less confusion (delirium) after heart valve surgery in people aged 65 and older. Delirium affects up to 70% of older heart surgery patients and can lead to longer hospital stays and memory probl…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Which wrist access lowers radiation for heart doctors? new trial aims to find out
Knowledge-focused Not yet recruitingThis study compares how much radiation doctors are exposed to during heart procedures (PCI) when using the left distal wrist versus the right wrist for artery access. About 748 patients scheduled for PCI will take part. The goal is to see if the left wrist approach reduces radiat…
Phase: NA • Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Can simulation make surgery safer? small study aims to find out
Knowledge-focused Not yet recruitingThis study will test a simulation-based training program for new surgical residents, anesthesia nurses, and operating room nurses. Participants will go through two 60-minute team training sessions with realistic scenarios and guided discussions. The goal is to see if this trainin…
Phase: NA • Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New thermometer aims to take core temperature from the skin
Knowledge-focused Not yet recruitingThis study will check if a new electronic thermometer (XST600) can accurately measure core body temperature when placed on the skin. Researchers will compare its readings to a standard thermometer used in hospitals. About 117 adults who need temperature monitoring will take part.
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New registry aims to crack the code on sudden drug allergies
Knowledge-focused Not yet recruitingThis study will create a registry of 200 adults who have had immediate allergic reactions to drugs, like hives or anaphylaxis within an hour of taking medication. Researchers will analyze blood samples and medical records to better understand the causes of these reactions. The go…
Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Sticky patch could replace wires for hospital heart monitoring
Knowledge-focused Not yet recruitingThis study tests a small, sticky patch that records heart rhythms in hospitalized patients who need continuous monitoring. The patch sends data to a central system for real-time alerts and later review. Researchers want to see if it helps doctors make faster decisions about treat…
Phase: NA • Sponsor: Yonsei University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC